drugset / Trial / NCT02931175

ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)

NCT02931175 ↗

Phase 2 Completed 28 enrolled Quan Dong Nguyen Mallinckrodt · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The study aims to evaluate the potential role of ACTH gel in the management of non-infectious uveitis.

Timeline

Start
2017-11-10
Primary completion
2020-04-03
Completion
2021-10-28

Drugs

EvaluationDrugModalityDoseRoute
Subject adrenocorticotropic hormone Unknown 80 iu Subcutaneous

Indications